Sign In
Buy GMED
$86.15
+3.80 (+4.61%)
At Close: Aug 10, 2026
Globus Medical Q2 Earnings Call Highlights
06:04am, Saturday, 08'th Aug 2026
Globus Medical NYSE: GMED reported second-quarter 2026 revenue of $789.6 million, up 6% from a year earlier, as growth in its spine and trauma businesses helped offset declines in enabling technologie
GMED Q2 Earnings Call Highlights Margin Gains and Revenue Caution
12:16pm, Friday, 07'th Aug 2026
Globus Medical raises 2026 EPS guidance after Q2 margin gains and spine growth while holding sales guidance steady amid Nevro and Enabling Technologies risks.
Globus Medical (GMED) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
09:01pm, Thursday, 06'th Aug 2026
While the top- and bottom-line numbers for Globus Medical (GMED) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics com
Globus Medical, Inc. (GMED) Q2 2026 Earnings Call Transcript
08:44pm, Thursday, 06'th Aug 2026
Globus Medical, Inc. (GMED) Q2 2026 Earnings Call Transcript
Globus Medical Reports Second Quarter 2026 Results
04:15pm, Thursday, 06'th Aug 2026
AUDUBON, Pa., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the second quarter ended June
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
10:41am, Thursday, 06'th Aug 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Globus Medical, Inc. $GMED Shares Purchased by Amundi
03:05am, Thursday, 06'th Aug 2026
Amundi raised its position in Globus Medical, Inc. (NYSE: GMED) by 12.2% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (S
What to Expect From These 2 MedTech Stocks This Earnings Season?
12:01pm, Wednesday, 05'th Aug 2026
Globus Medical and Resmed enter the earnings season with growth drivers intact despite tariff, inflation and hospital spending pressures.
Unlocking Q2 Potential of Globus Medical (GMED): Exploring Wall Street Estimates for Key Metrics
10:16am, Wednesday, 05'th Aug 2026
Get a deeper insight into the potential performance of Globus Medical (GMED) for the quarter ended June 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for
Globus Medical, Inc. $GMED Stock Holdings Boosted by California State Teachers Retirement System
04:13am, Tuesday, 04'th Aug 2026
California State Teachers Retirement System increased its position in Globus Medical, Inc. (NYSE: GMED) by 22.0% during the first quarter, according to the company in its most recent 13F filing with t
GMED's Q2 Earnings on Deck: Will Enabling Technologies Lead Results?
02:26pm, Friday, 31'st Jul 2026
Globus Medical will report Q2 results on Aug. 6. Investors will be keen to know whether Enabling Technologies and Spine strength aid revenue & earnings growth.
Kuehn Law Encourages Investors of Globus Medical, Inc. to Contact Law Firm
07:16pm, Tuesday, 28'th Jul 2026
NEW YORK, July 28, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Globus Medical, Inc. (NYSE: GMED) breached their
Globus Medical, Inc. $GMED Shares Bought by American Capital Management Inc.
03:50am, Tuesday, 28'th Jul 2026
American Capital Management Inc. grew its stake in Globus Medical, Inc. (NYSE: GMED) by 36.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission
Globus Medical, Inc. $GMED Shares Acquired by Dimensional Fund Advisors LP
04:13am, Monday, 27'th Jul 2026
Dimensional Fund Advisors LP raised its stake in Globus Medical, Inc. (NYSE: GMED) by 2.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission
Bank of New York Mellon Corp Trims Stock Position in Globus Medical, Inc. $GMED
03:39am, Thursday, 23'rd Jul 2026
Bank of New York Mellon Corp lessened its holdings in Globus Medical, Inc. (NYSE: GMED) by 1.4% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commi
